(S (NP (NN Histopathology)) (VP (VP (VBZ is) (NP (NP (DT a) (NN reflection)) (PP (IN of) (NP (DT the) (JJ molecular) (NNS changes))))) (CC and) (VP (VBZ provides) (NP (JJ prognostic) (NNS phenotypes)) (S (VP (VBG representing) (NP (DT the) (NN disease) (NN progression)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD introduced) (NP (NP (NN feature) (NNS scores)) (VP (VBN generated) (PP (IN from) (NP (NML (NN hematoxylin) (CC and) (NN eosin)) (NN histology) (NNS images))) (PP (VBN based) (PP (IN on) (NP (NP (NML (NML (JJ deep) (NN learning)) (-LRB- -LRB-) (NML (NN DL)) (-RRB- -RRB-)) (NNS models)) (VP (VBN developed) (PP (IN for) (NP (NN prostate) (NN pathology)))))))))) (. .))
(S (NP (PRP We)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (DT these) (NN feature) (NNS scores)) (VP (VP (VBD were) (ADJP (RB significantly) (JJ prognostic) (PP (IN for) (NP (NN time)))) (PP (IN to) (NP (NP (NN event) (NNS endpoints)) (-LRB- -LRB-) (NP (NP (JJ biochemical) (NN recurrence)) (CC and) (NP (ADJP (NN cancer) (HYPH -) (JJ specific)) (NN survival))) (-RRB- -RRB-)))) (CC and) (VP (VBD had) (NP (NP (ADVP (RB simultaneously)) (NP (JJ molecular) (JJ biologic) (NNS associations)) (PP (IN to) (NP (JJ relevant) (JJ genomic) (NNS alterations)))) (CC and) (NP (NP (JJ molecular) (NNS subtypes)) (VP (VBG using) (NP (NP (ADJP (RB already) (VBN trained)) (NN DL) (NNS models)) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (RB not) (ADVP (RB previously)) (VP (VBN exposed) (PP (IN to) (NP (NP (DT the) (NNS datasets)) (PP (IN of) (NP (DT the) (JJ current) (NN study)))))))))))))))))) (. .))
(S (ADVP (RB Further)) (, ,) (NP (PRP we)) (VP (VBD discussed) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (JJ such) (NN feature) (NNS scores)))) (S (VP (TO to) (VP (VB improve) (NP (NP (DT the) (NML (JJ current) (NN tumor)) (VBG grading) (NN system)) (CC and) (NP (NP (DT the) (NNS challenges)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NP (NN tumor) (NN heterogeneity)) (CC and) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ prognostic) (NNS models)))))) (PP (IN from) (NP (NN histology) (NNS images))))))))))))) (. .))
(S (NP (PRP$ Our) (NNS findings)) (VP (VBP uncover) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NN feature) (NNS scores)))) (PP (PP (IN from) (NP (NP (NN histology) (NNS images)) (PP (IN as) (NP (NP (JJ digital) (NNS biomarkers)) (PP (IN in) (NP (NN precision) (NN medicine))))))) (CC and) (PP (IN as) (NP (NP (DT an) (VBG expanding) (NN utility)) (PP (IN for) (NP (JJ digital) (NN pathology))))))) (. .))
